Browse by Medical Category
Not Accepting New Patients
Anthony Rosenzweig, MD, is the chief of cardiology and co-director of the Corrigan Minehan Heart Center. He specializes in general noninvasive cardiology, with a particular interest in cardiovascular genetics and cardiovascular disease prevention.
Go To Programs
Go To Programs
Go To Specialties
Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.
Anthony Rosenzweig, MD, is the chief of cardiology at Massachusetts General Hospital and co-director of the Corrigan Minehan Heart Center. He specializes in general noninvasive cardiology, with a particular interest in cardiovascular genetics and cardiovascular disease prevention.Dr. Rosenzweig attended Harvard Medical School, and completed his medical residency and cardiology fellowship at Mass General. His clinical interests include noninvasive clinical cardiology, cardiovascular genetics and cardiovascular disease prevention.Dr. Rosenzweig practiced cardiology at Mass General, where he studied causes of heart failure and served as the director of the Cardiovascular Gene Therapy Program. He joined Beth Israel Deaconess Medical Center in 2006 as the director of cardiovascular research and associate chief of the Cardiovascular Division where he led the recruitment of investigators in the cardiovascular research program.Dr. Rosenzweig is a widely published expert on mechanisms of heart failure and the benefits of exercise, and presents internationally on his research. He is also a member of numerous medical societies and has served in leadership roles within these institutions. He has published more than 150 scientific papers and his research has been continuously funded for more than twenty years.Dr. Rosenzweig has held various leadership roles, including American Coordinator for a Leducq Foundation Network of Research Excellence, comprising 11 laboratories in Europe and the United States. He was also an associate editor of the New England Journal of Medicine from 2003 to 2013 and has served on numerous editorial boards including Cell Metabolism and Circulation Research.
View my most recent publications at PubMed
A team led by Massachusetts General Hospital (MGH) investigators has found that activity of an important signaling pathway increases with aging and with heart failure and that inhibiting that pathway can improve cardiac function in mouse models.
Research at the MGH is interwoven throughout more than 30 departments, centers and units and is conducted with the support and guidance of the MGH Research Institute. The Research Roundup is a monthly series highlighting studies, news and events.
Almost 200 MGH staffers, patients and family members joined over 10,000 walkers on the Charles River Esplanade on Sept. 12 to participate in the 2015 AHA Boston Heart Walk.
Back to Top